Alkermes (ALKS) Free Cash Flow (2010 - 2026)
Alkermes (ALKS) reported Free Cash Flow of -$169.8 million for Q1 2026, down 291.47% year-over-year from $88.7 million in Q1 2025, and down 199.85% quarter-over-quarter from $170.1 million in Q4 2025.
Alkermes (ALKS) Free Cash Flow (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Free Cash Flow data on file, last reported at -$169.8 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$169.8 million, down 291.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $221.8 million (down 53.94% YoY), and the FY2025 annual result was $480.3 million, up 18.41% from the prior year.
- Free Cash Flow slipped to -$169.8 million in Q1 2026 per ALKS's latest filing, from $170.1 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $206.0 million in Q2 2023 and troughed at -$169.8 million in Q1 2026.
- A 5-year average of $61.9 million and a median of $84.4 million in 2025 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 1779.21% in 2023 and fell as far as 302.79% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$9.0 million in 2022, then surged by 1104.42% to $90.2 million in 2023, then soared by 100.23% to $180.6 million in 2024, then retreated by 5.83% to $170.1 million in 2025, then tumbled by 199.85% to -$169.8 million in 2026.
- Business Quant data shows ALKS's Free Cash Flow at -$169.8 million in Q1 2026, $170.1 million in Q4 2025, and $84.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 46.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -169.83 Mn |
| Mar 31, 2026 | -169.83 Mn |
| Dec 31, 2025 | 170.09 Mn |
| Dec 31, 2025 | 170.09 Mn |
| Sep 30, 2025 | 84.36 Mn |
| Sep 30, 2025 | 84.36 Mn |
| Jun 30, 2025 | 137.19 Mn |
| Jun 30, 2025 | 137.19 Mn |
| Mar 31, 2025 | 88.70 Mn |
| Mar 31, 2025 | 88.70 Mn |
| Dec 31, 2024 | 180.62 Mn |
| Dec 31, 2024 | 180.62 Mn |
| Sep 30, 2024 | 73.33 Mn |
| Sep 30, 2024 | 73.33 Mn |
| Jun 30, 2024 | 138.92 Mn |
| Jun 30, 2024 | 138.92 Mn |
| Mar 31, 2024 | 12.77 Mn |
| Mar 31, 2024 | 12.77 Mn |
| Dec 31, 2023 | 90.21 Mn |
| Dec 31, 2023 | 90.21 Mn |